Akèy › Anplwayè › Sumitomo Pharma Oncology, Inc.
Sumitomo Pharma Oncology, Inc.: Salè H-1B ak pajon
Sumitomo Pharma Oncology, Inc. depoze 4 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 4. Medyèn salè yo ofri a: $131,412.
Èske Sumitomo Pharma Oncology, Inc. pajone visa H-1B?
Sumitomo Pharma Oncology, Inc. depoze 4 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 25, 2023. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Associate Director, Pharmacovigilance Systems | 1 | $166,036 |
| Senior Manager, Accounting | 1 | $148,526 |
| Scientist I, Translational Biology | 1 | $109,408 |
| Manager, Quality Management Systems | 1 | $114,298 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 4 | $131,412 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Bioengineers and Biomedical Engineers1
- Accountants and Auditors1
- Molecular and Cellular Biologists1
- Regulatory Affairs Specialists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Scientist I, Translational Biology | $109,408 Nivo III | Suite 100, UT | Apr 25, 2023 | Oct 1, 2023 | Certifye |
| Manager, Quality Management Systems | $114,298 Nivo II | Marlborough, MA | Apr 3, 2023 | Aug 3, 2023 | Certifye |
| Senior Manager, Accounting | $148,526 E-3 · Nivo IV | Marlborough, MA | Dec 28, 2022 | May 6, 2023 | Certifye |
| Associate Director, Pharmacovigilance Systems | $166,036 Nivo IV | Marlborough, MA | Oct 25, 2022 | Mar 23, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).